TRICYCLIC ERYTHROMYCIN DERIVATIVES
    1.
    发明申请
    TRICYCLIC ERYTHROMYCIN DERIVATIVES 审中-公开
    三硫化红霉素衍生物

    公开(公告)号:WO1998030574A1

    公开(公告)日:1998-07-16

    申请号:PCT/US1997005871

    申请日:1997-04-07

    CPC classification number: C07H17/08 C07H17/00

    Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of formulas: (I); (II); (III); or (IV); wherein A, B, D and E, R , R , and Z specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of bacterial infections with such compositions, and processes for the preparation of the compounds.

    Abstract translation: 化合物或其药学上可接受的盐和酯,其具有下式:(I); (II); (III); 或(IV); 其特征在于具有抗菌活性的A,B,D和E,R 1,R 2和Z,含有所述化合物的药物组合物,用这些组合物治疗细菌感染,以及制备化合物的方法 。

    TRICYCLIC ERYTHROMYCIN DERIVATIVES
    2.
    发明申请
    TRICYCLIC ERYTHROMYCIN DERIVATIVES 审中-公开
    三硫化红霉素衍生物

    公开(公告)号:WO1997017356A1

    公开(公告)日:1997-05-15

    申请号:PCT/US1996016585

    申请日:1996-10-17

    CPC classification number: C07H17/08

    Abstract: Compounds, or pharmaceutically acceptable salts and esters thereof, of formulae (I); (II); (III) or (IV) wherein A, B, D and E, R , R and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of antibacterial infections with such compositions, and processes for the preparation of the compounds.

    Abstract translation: 式(I)的化合物或其药学上可接受的盐和酯; (II); (III)或(IV)其中A,B,D和E,R 1,R 2和Z具体定义为具有抗菌活性,含有所述化合物的药物组合物,用这些组合物治疗抗菌感染,以及 制备化合物的方法。

    QUINOBENZOXAZINE, QUINOBENZOTHIAZINE, AND PYRIDO-ACRIDINE ANTINEOPLASTIC AGENTS
    3.
    发明申请
    QUINOBENZOXAZINE, QUINOBENZOTHIAZINE, AND PYRIDO-ACRIDINE ANTINEOPLASTIC AGENTS 审中-公开
    喹诺酮类,喹诺酮类和吡虫啉类抗生素

    公开(公告)号:WO1993016702A1

    公开(公告)日:1993-09-02

    申请号:PCT/US1993001766

    申请日:1993-02-26

    Abstract: Quinobenzoxazine, quinobenzothiazines, and pyrido-acridine derivatives of formula (I) as well as the pharmaceutically acceptable salts, esters, amides and prodrugs thereof are disclosed, wherein R is hydrogen or acarboxy-protecting group, R and R are substituents, A is oxygen, sulfur, or carbon, Z is a halogen or a nitrogen-containing group, X is hydrogen, halogen or alkyl, and W is hydrogen, alkyl, amino or halogen. The compounds have potent antineoplastic activity.

    Abstract translation: 公开了式(I)的喹苯并恶嗪,喹苯并噻嗪和吡啶并吖啶衍生物及其药学上可接受的盐,酯,酰胺和前药,其中R 1是氢或酰氧基保护基,R 2和R 3是取代基,A是氧,硫或碳,Z是卤素或含氮基团,X是氢,卤素或烷基,W是氢,烷基,氨基或卤素。 这些化合物具有有效的抗肿瘤活性。

    QUINOBENZOXAZINE, QUINOBENZOTHIAZINE, AND PYRIDO-ACRIDINE ANTINEOPLASTIC AGENTS
    4.
    发明公开
    QUINOBENZOXAZINE, QUINOBENZOTHIAZINE, AND PYRIDO-ACRIDINE ANTINEOPLASTIC AGENTS 失效
    基于CHINOBENZOXAZINEN,CHINOBENZOTHIAZINEN和吡啶并吖啶抗肿瘤物质。

    公开(公告)号:EP0608215A1

    公开(公告)日:1994-08-03

    申请号:EP91918185.0

    申请日:1991-08-23

    CPC classification number: C07D455/00 C07D513/06 Y02P20/55

    Abstract: L'invention se rapporte à de la quinobenzoxazine, des quinobenzothiazines et des dérivés de pyrido-acridine, représentés par la formule (I), ainsi qu'à leurs sels, esters, amides, et pro-médicaments pharmaceutiquement acceptables. Dans la formule (I), R1 représente hydrogène ou un groupe protecteur de carboxy, R2 et R3 représentent des substituants, A représente oxygène, soufre ou carbone, Z représente un halogène ou un groupe contenant de l'azote, X représente hydrogène, halogène ou alkyle, et W représente hydrogène, alkyle, amino ou halogène. Ces composés ont un pouvoir antinéoplastique puissant.

Patent Agency Ranking